Non-aortic cardiovascular disease in Marfan syndrome: a nationwide epidemiological study
- 22 April 2021
- journal article
- research article
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 110 (7) , 1106-1115
Abstract
Objectives Studies indicate that other cardiovascular problems than aortic disease are a burden for patients with Marfan syndrome (MFS). The aim of the study was to assess the extent of this issue. Methods A registry-based population study of patients with a Ghent II verified MFS diagnosis. Each patient was matched with up to 100 controls on age and sex. From the Danish healthcare system, we identified 407 MFS patients (from 1977 to 2014) and their cardiovascular events and compared them with those in 40,700 controls. Total follow-up time was 16,439 person years. Results Mitral valve disease was significantly more common in MFS [HR: 58.9 (CI 38.1–91.1)] and happened earlier and more often in women than men with MFS [age at first registration: 22 vs. 38 years, HR: 2.1 (CI 1.0–4.4)]. Heart failure/cardiomyopathy was also more common in MFS [HR: 8.7 (CI 5.7–13.4)] and men were more affected than women, and at younger age [39 vs. 64 years, HR: 0.18 (CI 0.06–0.55)]. In all cases, atrioventricular block [HR: 4.9 (1.5–15.6)] was related to heart surgery. Supraventricular [HR: 9.7 (CI 7.5–12.7)] and ventricular tachycardia [HR: 7.7 (CI 4.2–14.3)] also occurred more often than in the control group. The risk of sudden cardiac death was increased [HR: 8.3 (CI 3.8–18.0)] but the etiology was unclear due to lack of autopsies. Conclusion Non-aortic cardiovascular disease in patients with MFS is exceptionally prevalent and the range of diseases varies between women and men. Physicians caring for MFS patients must be aware of this large spectrum of cardiovascular diseases. Graphical abstractKeywords
This publication has 47 references indexed in Scilit:
- Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed PrescriptionsClinical Epidemiology, 2012
- Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome MiceScience, 2011
- Frequency and Age-Related Course of Mitral Valve Dysfunction in the Marfan SyndromeThe American Journal of Cardiology, 2010
- Marfan syndrome. Part 1: pathophysiology and diagnosisNature Reviews Cardiology, 2010
- The unravelling of primary myocardial impairment in Marfan syndrome by modern echocardiographyHeart, 2009
- Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan SyndromeScience, 2006
- Evaluation of left ventricular dimensions and function in Marfan's syndrome without significant valvular regurgitationThe American Journal of Cardiology, 2005
- Resistant hypertension in patients with chronic aortic dissectionJournal of Human Hypertension, 2004
- Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death?JACC, 2003
- Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin geneNature, 1991